share_log

Why Anhui Hongyu Wuzhou Medical ManufacturerLTD's (SZSE:301234) Shaky Earnings Are Just The Beginning Of Its Problems

Why Anhui Hongyu Wuzhou Medical ManufacturerLTD's (SZSE:301234) Shaky Earnings Are Just The Beginning Of Its Problems

为什么安徽宏宇五洲医疗器械制造有限公司(SZSE: 301234)不稳定的收益只是问题的开始
Simply Wall St ·  04/22 19:47

The market wasn't impressed with the soft earnings from Anhui Hongyu Wuzhou Medical Manufacturer Co.,LTD. (SZSE:301234) recently. We did some analysis, and found that there are some reasons to be cautious about the headline numbers.

安徽宏宇五洲医疗器械制造有限公司的疲软收益并没有给市场留下深刻的印象。, LTD.(SZSE: 301234) 最近。我们做了一些分析,发现有一些理由对标题数字持谨慎态度。

earnings-and-revenue-history
SZSE:301234 Earnings and Revenue History April 22nd 2024
SZSE: 301234 2024 年 4 月 22 日的收益和收入记录

How Do Unusual Items Influence Profit?

不寻常的物品如何影响利润?

For anyone who wants to understand Anhui Hongyu Wuzhou Medical ManufacturerLTD's profit beyond the statutory numbers, it's important to note that during the last twelve months statutory profit gained from CN¥4.6m worth of unusual items. While we like to see profit increases, we tend to be a little more cautious when unusual items have made a big contribution. We ran the numbers on most publicly listed companies worldwide, and it's very common for unusual items to be once-off in nature. Which is hardly surprising, given the name. If Anhui Hongyu Wuzhou Medical ManufacturerLTD doesn't see that contribution repeat, then all else being equal we'd expect its profit to drop over the current year.

对于任何想了解安徽宏宇五洲医疗制造有限公司在法定数字之外的利润的人来说,值得注意的是,在过去的十二个月中,从价值460万元人民币的不寻常物品中获得了法定利润。虽然我们希望看到利润增加,但当不寻常的物品做出重大贡献时,我们往往会更加谨慎一些。我们统计了全球大多数上市公司的数字,不寻常的物品在自然界中很常见。考虑到这个名字,这并不奇怪。如果安徽宏宇五洲医疗器械制造有限公司不认为这种捐款重演,那么在其他条件相同的情况下,我们预计其本年度的利润将下降。

Note: we always recommend investors check balance sheet strength. Click here to be taken to our balance sheet analysis of Anhui Hongyu Wuzhou Medical ManufacturerLTD.

注意:我们始终建议投资者检查资产负债表的实力。点击此处查看我们对安徽宏宇五洲医药制造有限公司的资产负债表分析

Our Take On Anhui Hongyu Wuzhou Medical ManufacturerLTD's Profit Performance

我们对安徽宏宇五洲医疗器械制造有限公司盈利表现的看法

Arguably, Anhui Hongyu Wuzhou Medical ManufacturerLTD's statutory earnings have been distorted by unusual items boosting profit. Therefore, it seems possible to us that Anhui Hongyu Wuzhou Medical ManufacturerLTD's true underlying earnings power is actually less than its statutory profit. Sadly, its EPS was down over the last twelve months. At the end of the day, it's essential to consider more than just the factors above, if you want to understand the company properly. With this in mind, we wouldn't consider investing in a stock unless we had a thorough understanding of the risks. At Simply Wall St, we found 2 warning signs for Anhui Hongyu Wuzhou Medical ManufacturerLTD and we think they deserve your attention.

可以说,安徽宏宇五洲医疗器械制造有限公司的法定收益被提高利润的不寻常项目所扭曲。因此,在我们看来,安徽宏宇五洲医疗制造有限公司的真正基础盈利能力实际上可能低于其法定利润。不幸的是,在过去的十二个月中,其每股收益有所下降。归根结底,如果你想正确地了解公司,必须考虑的不仅仅是上述因素。考虑到这一点,除非我们对风险有透彻的了解,否则我们不会考虑投资股票。在Simply Wall St,我们发现了安徽红宇五洲医疗器械制造有限公司的两个警告标志,我们认为它们值得你关注。

Today we've zoomed in on a single data point to better understand the nature of Anhui Hongyu Wuzhou Medical ManufacturerLTD's profit. But there is always more to discover if you are capable of focussing your mind on minutiae. Some people consider a high return on equity to be a good sign of a quality business. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying to be useful.

今天,我们放大了单一数据点,以更好地了解安徽宏宇五洲医疗器械制造有限公司利润的性质。但是,如果你能够将注意力集中在细节上,总会有更多的事情需要发现。有些人认为高股本回报率是优质业务的好兆头。虽然可能需要你进行一些研究,但你可能会发现这份免费收集的拥有高股本回报率的公司,或者这份内部人士正在购买的股票清单很有用。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发